| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |